Management of Adverse Events of Check Point Inhibitors (CPI) and Antibody Drug Conjugates (ADC) in Solid Tumors

Management of Adverse Events of Check Point Inhibitors (CPI) and Antibody Drug Conjugates (ADC) in Solid Tumors

0% Complete

Course Overview

NA

Course Content

Management of Adverse Events of Check Point Inhibitors (CPI) and Antibody Drug Conjugates (ADC) in Solid Tumors

Course Details

Duration
0.00 hour
Released
May 14, 2025
Last Review
May 14, 2025
Expires
May 14, 2028

Objectives

NA

Target Audience

NA

Faculty & Disclosure

Faculty

Meri Muminovic, MD

Disclosure

Meri Muminovic, MD discloses no such relationships exist

Accreditation

NA

Related Courses

2026 MCM | Applications of MRD Concept in Solid Tumors

2026 MCM | Applications of MRD Concept in Solid Tumors

0.00 AMA PRA Category 1 Credits™
1 Chapter
Solid Tumor
Free
2026 MCM | What Do You Need to Know About ADC Toxicity in Solid Tumors? Most Common Adverse Events

2026 MCM | What Do You Need to Know About ADC Toxicity in Solid Tumors? Most Common Adverse Events

0.00 AMA PRA Category 1 Credits™
1 Chapter
Solid Tumor
Free
Explore More Courses